Luca Messerini

About Luca Messerini

Luca Messerini, With an exceptional h-index of 50 and a recent h-index of 24 (since 2020), a distinguished researcher at Università degli Studi di Firenze, specializes in the field of Oncologia.

His recent articles reflect a diverse array of research interests and contributions to the field:

Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients

Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients

MRI of peliosis hepatis: A case series presentation with a 2022 systematic literature update

The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs

Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1)

MSI analysis in patients with GIST with lynch syndrome.

miRNAs targeting RAS and their clinical relevance in resected pancreatic adenocarcinoma (PC): Results from a prospective study.

Prognostic factors across poorly differentiated neuroendocrine neoplasms: a pooled analysis

Luca Messerini Information

University

Position

Professore Anatomia Patologica

Citations(all)

6719

Citations(since 2020)

1727

Cited By

5619

hIndex(all)

50

hIndex(since 2020)

24

i10Index(all)

99

i10Index(since 2020)

58

Email

University Profile Page

Google Scholar

Luca Messerini Skills & Research Interests

Oncologia

Top articles of Luca Messerini

Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients

Pancreatology

2024/3/15

Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients

Heliyon

2023/11/1

Luca Messerini
Luca Messerini

H-Index: 26

MRI of peliosis hepatis: A case series presentation with a 2022 systematic literature update

Journal of Magnetic Resonance Imaging

2023/11

Cosimo Nardi
Cosimo Nardi

H-Index: 14

Luca Messerini
Luca Messerini

H-Index: 26

The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs

Cancer Letters

2023/9/1

Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1)

Endocrine

2023/9

MSI analysis in patients with GIST with lynch syndrome.

2023/6/1

miRNAs targeting RAS and their clinical relevance in resected pancreatic adenocarcinoma (PC): Results from a prospective study.

2023/6/1

Prognostic factors across poorly differentiated neuroendocrine neoplasms: a pooled analysis

Neuroendocrinology

2023/3/22

KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients

Frontiers in Oncology

2023

Herg1 potassium channel expression in colorectal adenomas: Comparison with other preneoplastic lesions of the gastrointestinal tract

Current Issues in Molecular Biology

2022/3/17

Maria Raffaella Ambrosio
Maria Raffaella Ambrosio

H-Index: 17

Luca Messerini
Luca Messerini

H-Index: 26

Correlation of CT radiomic features for GISTs with pathological classification and molecular subtypes: Preliminary and monocentric experience

La radiologia medica

2022/2

Luca Messerini
Luca Messerini

H-Index: 26

Daniela Massi
Daniela Massi

H-Index: 38

Prognostic role of hERG1 potassium channels in neuroendocrine tumours of the ileum and pancreas

International Journal of Molecular Sciences

2022/9/13

Artificial intelligence predictive models of response to cytotoxic chemotherapy alone or combined to targeted therapy for metastatic colorectal cancer patients: a systematic …

2022/8/19

Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver

Internal and Emergency Medicine

2021/9

Luca Messerini
Luca Messerini

H-Index: 26

Neonatal Nav1. 5 protein expression in human colorectal cancer: Immunohistochemical characterization and clinical evaluation

Cancers

2021/7/30

Luca Messerini
Luca Messerini

H-Index: 26

Giuseppe Perrone
Giuseppe Perrone

H-Index: 20

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study

British journal of cancer

2021/7/6

Luca Messerini
Luca Messerini

H-Index: 26

Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors.

2021/5/20

Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis

Endocrine

2021/4

KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy …

Oncology Letters

2021/1/1

Luca Messerini
Luca Messerini

H-Index: 26

ROS1 rearrangements are uncommon in biliary tract cancers

Oncology Letters

2020/12/1

See List of Professors in Luca Messerini University(Università degli Studi di Firenze)